A peptide prodrug strategy for increasing oral bioavailability

peptide prodrug strategy designed to target the intestinal peptide transporter to increase absorption and then to target the cytosolic prolidase as the prodrug converting enzyme to release the drug from the peptide prodrug inside the cell was studied.;The transport studies suggested that the peptide prodrug without the N-terminal...